Tiziana Appoints Board Member
This article was originally published in Scrip
Executive Summary
Tiziana Life Sciences PLC. has appointed Willy Jules Simon to its board as non-executive director. Simon is a banker and most recently was chair of AIM-traded Velox3 PLC. and director of Playlogic Entertainment Inc. Previously he served as chief executive for Fortis Investment Management, on the board of Generale Bank NL and worked at Kredietbank N.V. and Citibank London. Simon has also acted as chair of Bank Oyens and van Eeghen.
You may also be interested in...
Text Mining And Machine Reading: The Answer To Pharma's R&D Data Mountain?
How to make the most of the wealth of raw data in pharmaceutical R&D is an increasing challenge for the industry. The digital revolution is already having an impact in areas like clinical trials, and pharma is also starting to embrace new technologies in drug discovery.
Adherence Issues Add Weight To Digital Trials Push
Technology advancement has brought a wave of change in healthcare, with an increasing number of key pharma players now recognizing the potential of digital – particularly in clinical trials.
Appointments: Five Prime, Depomed, Gilead, Arix Bioscience and Corbus
This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.